Article: Optimizing Catheter Positioning Improves Drug Distribution of Cintredekin Besudotox via Convection Enhanced Delivery.

WAUKEGAN, Ill. -- Optimal Catheter Positioning Improves Survival Benefit

NeoPharm, Inc. (Nasdaq:NEOL) today announced that the use of a novel software-based catheter planning and positioning system developed by BrainLAB AG may optimize the efficacy and safety of tumor targeting therapies delivered via Convection Enhanced Delivery (CED), specifically cintredekin besudotox (IL13-PE38QQRR), an investigational treatment being studied for the treatment of patients with first recurrent glioblastoma multiforme.

In a study presented via poster presentation today by John Sampson, MD, Associate Professor of Neurosurgery and Assistant Professor of Pathology at ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!